*<p>Immunohistochemistry staining with L858R-specific antibody was not evaluable in total of the tumours included in the study of <i>EGFR</i> mutations using PCR based methods.</p
<p>N.D., not determined.</p>§<p>No adequate DNA quantity was available for sensitivity study for two...
In recent years, it has been well known that non-small cell lung cancer (NSCLC) patients with mutati...
a)<p>EGFR mutation status including wild-type (WT), E746-A750 del (del), L858R and T790M was determi...
<p>IHC, immunohistochemistry.</p>*<p>Immunohistochemistry staining with the L858R-specific antibody ...
The objective of this study is to compare two EGFR testing methodologies (a commercial real-time PCR...
The objective of this study is to compare two EGFR testing methodologies (a commercial real-time PCR...
Background: The recent development of antibodies specific for the major hotspot mutations in the epi...
Aims Identification of epidermal growth factor receptor (EGFR) mutations in lung adenocarcinomas is ...
*<p>:The cases with both E19 (E746–A750) and E21 (L858R) mutations were not counted twice.</p><p>Oth...
<p>The total EGFR protein in cytology samples could be stained with EGFR (D38B1) antibody (A, D and ...
EGFR mutation testing of tumor samples is routinely performed to predict sensitivity to treatment wi...
EGFR mutations are the best predictors of response to EGFR kinase inhibitors in lung adenocarcinoma....
#<p>The <i>EGFR</i> mutation analysis by direct sequencing was not evaluable for three of the tumour...
<p>Total EGFR antibody stained all four histological and cytological samples. Anti-delE746-A750 anti...
<p>The total EGFR protein in resection samples could be stained with EGFR (D38B1) antibody (<b>A</b>...
<p>N.D., not determined.</p>§<p>No adequate DNA quantity was available for sensitivity study for two...
In recent years, it has been well known that non-small cell lung cancer (NSCLC) patients with mutati...
a)<p>EGFR mutation status including wild-type (WT), E746-A750 del (del), L858R and T790M was determi...
<p>IHC, immunohistochemistry.</p>*<p>Immunohistochemistry staining with the L858R-specific antibody ...
The objective of this study is to compare two EGFR testing methodologies (a commercial real-time PCR...
The objective of this study is to compare two EGFR testing methodologies (a commercial real-time PCR...
Background: The recent development of antibodies specific for the major hotspot mutations in the epi...
Aims Identification of epidermal growth factor receptor (EGFR) mutations in lung adenocarcinomas is ...
*<p>:The cases with both E19 (E746–A750) and E21 (L858R) mutations were not counted twice.</p><p>Oth...
<p>The total EGFR protein in cytology samples could be stained with EGFR (D38B1) antibody (A, D and ...
EGFR mutation testing of tumor samples is routinely performed to predict sensitivity to treatment wi...
EGFR mutations are the best predictors of response to EGFR kinase inhibitors in lung adenocarcinoma....
#<p>The <i>EGFR</i> mutation analysis by direct sequencing was not evaluable for three of the tumour...
<p>Total EGFR antibody stained all four histological and cytological samples. Anti-delE746-A750 anti...
<p>The total EGFR protein in resection samples could be stained with EGFR (D38B1) antibody (<b>A</b>...
<p>N.D., not determined.</p>§<p>No adequate DNA quantity was available for sensitivity study for two...
In recent years, it has been well known that non-small cell lung cancer (NSCLC) patients with mutati...
a)<p>EGFR mutation status including wild-type (WT), E746-A750 del (del), L858R and T790M was determi...